SHANGHAI, May 9, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it will release its unaudited financial results for the first quarter 2011 ended March 31, 2011 on May 19, 2011. Management will host a conference call to discuss the results at 8:00am New York Time on May 19, 2011 (8:00pm Beijing time on May 19, 2011).
Conference Call Mr. Michael Hui, founder and Chief Executive Officer, Mr. Kevin Chen, President and Chief Operating Officer, and Mr. William Dai, Chief Financial Officer, will discuss the results and take questions following the prepared remarks.
The dial-in details for the live conference call are as follows:- U.S. Toll Free Number:
1.888.396.2369- International dial-in number:1.617.847.8710- China Toll Free Number:
10 800 152 1490 (North)10 800 852 1490 (South)- Hong Kong Toll Free Number:
800 96 3844Passcode:
A telephone replay of the call will be available for seven days from May 19, 2011 to May 26, 2011. The dial-in details for the replay are as follows: - U.S. Toll Free Number:
1-888-286-8010- International dial-in number:1-617-801-6888Passcode:
64510327About ShangPharma Corp.ShangPharma Corporation is a leading China-based contract research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit www.shangpharma.com.
For further information, contact:ShangPharma CorporationLan Xie, VP of Finance and OperationsE-mail: IR@shangpharma.comChristensenIn New YorkKimberly Minarovich,Phone: +1 917-533-3268E-mail: email@example.comIn Hong KongTip FlemingPhone: +852-9212-0684Email: tfleming@ChristensenIR.com
|SOURCE ShangPharma Corporation|
Copyright©2010 PR Newswire.
All rights reserved